|
Pharmacological Group: Antineoplastics, Active Ingredient: Docetaxel, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 20, Unit: Mg/Ml, Volume: 4 Ml, Presentation: Ampoule Vial, Accessory: Diluent 4 Ml, Supply Form: Unit, Active Ingredient: Exemestane, Pharmaceutical Form: Dragee, Concentration / Dosage: 25, Unit: Mg, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Pharmacological Group: Antineoplastic, Active Ingredient: Fulvestrane, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration / Dosage: 250, Volume: N/A, Presentation: Ampoule Bottle, Accessory: N/A, Group Pharmacological: Thyroid Hormones And Thyroid Function Inhibitors, Active Ingredient: Alfathyrotropin (Recombinant Tsh), Pharmaceutical Form: Lyophilic Powder For Sun. Inj., Concentration / Dosage: 0.9, Volume: N/A, Accessory: Diluent, Pharmacological Group: Antineoplastics/Alkaloids, Active Ingredient: Vinorelbine Tartrate, Pharmaceutical Form: Hard Gelatin Capsule, Concentration / Dosage: 30, Presentation: N/A
|
